Rhopressa passed second phase III today in Glaucom
Post# of 30028
(Total Views: 286)
Posted On: 12/18/2017 4:32:42 PM
.jpg)
Re: jamiejaytrader #25645
Rhopressa passed second phase III today in Glaucoma. First new treatment, not cure/prevention, in 25 years. Aerie Pharma is a company purely devoted to Glaucoma with a short but very successful pipeline that's about to be swimming in cash. They would be a stellar partner for MANF Tx.
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼